8-K
filed May 11, 2026, 7:59 PM ET
ticker MLTX
CIK 0001821586
regulatory
confidence high
sentiment positive
materiality 0.85
MoonLake aligns with FDA on BLA for sonelokimab in HS; Q1 cash $357.9M
MoonLake Immunotherapeutics
- FDA pre-BLA meeting positive; alignment on submission plans, adolescent data inclusion, and safety strategy.
- BLA submission planned for end of Sep 2026; Priority Review decision expected within 60 days.
- Proposed label includes ~43% HiSCR75 response and ~29pp delta-to-placebo from MIRA trial, highest in HS.
- Cash $357.9M as of Mar 31, 2026; runway to end of 2027; up to $400M non-dilutive debt facility available.
- R&D expenses $54.5M (stable); G&A $15.5M with $4.8M accelerated stock option cancellation.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001821586-26-000005
- form_type
- 8-K
- ticker
- MLTX
- cik
- 0001821586
- company_name
- MoonLake Immunotherapeutics
- filed_at
- 2026-05-11T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.009000+00:00
- generated_at
- 2026-05-14T18:54:20.541971+00:00
- sec_items
- ["2.02", "7.01", "9.01"]
- event_type
- regulatory
- sentiment
- positive
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001821586-26-000005
- json_url
- https://secwatch.observer/filing/0001821586-26-000005.json
- markdown_url
- https://secwatch.observer/filing/0001821586-26-000005.md
- text_url
- https://secwatch.observer/filing/0001821586-26-000005.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1821586/000182158626000005/0001821586-26-000005-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1821586/000182158626000005/mnlk-20260510.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
HPE
HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework
Hewlett Packard Enterprise Co
June 1, 2026, 4:09 PM ET
earnings
Items 1.01, 2.02, 5.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
gross margin, and non-GAAP diluted net EPS, as well as its highest-ever free cash flow generation for a second quarter. Second Quarter Fiscal 2026 Financial Results • Revenue : $10.7 billion, up 40% from the prior-year period • Gross margins : ◦ GAAP of 36.5%, up 810 basis points from the prior-year period and up 60 basis points sequentially ◦ Non-GAAP (1) of 36.9%,
Filing page
SEC filing
ACH
Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization
ACCENDRA HEALTH INC/VA/
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
Commission this morning. Details on First Quarter 2026 Results First Quarter Results (1) ($ in millions, except per share data) 1Q26 1Q25 Net Revenue $ 627.8 $ 673.9 Loss from continuing operations, net of tax, GAAP $ (6.5) $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP $ (3.1) $ 23.2
Filing page
SEC filing
FSK
FSK posts Q1 GAAP loss of $1.57/sh, NAV falls to $18.83; announces $150M preferred, tender, buyback
FS KKR Capital Corp
May 11, 2026, 7:59 PM ET
earnings
Items 1.01, 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
Earnings (Loss) per share of ($1.57), compared to Earnings (Loss) per share of ($0.41) for the quarter ended December 31, 2025
Filing page
SEC filing
SBET
Sharplink Q1 revenue $12.1M, net loss $685.6M; plans $125M Galaxy Onchain Yield Fund
Sharplink, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
First Quarter 2026 Highlights Income Statement and Balance Sheet ● Total revenue increased materially to $12.1 million in Q1 2026, compared to $0.7 million for the three months ended March 31, 2025. The increase was primarily driven by the continued success of Sharplink’s actively managed ETH treasury strategy, which was launched on June 2, 2025. ● SG&A expenses were $9.9 million for the three months ended March 31, 2026, compared to $1.1 million in the prior year’s first quarter. The increase was primarily due to expenditures for investments in infrastructure, talent and systems required to scale and actively manage Sharplink’s institutional-grade ETH treasury platform. ● Net loss was $685.6 million in Q1 2026, compared to $1.0 million for the three months ended March 31, 2025.
Filing page
SEC filing
CONSTELLATION ENERGY GENERATION LLC
Constellation Q1 adjusted EPS $2.74 beats prior year $2.14; affirms FY guidance $11-$12
CONSTELLATION ENERGY GENERATION LLC
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
GAAP Net Income of $4.49 per share and Adjusted (non-GAAP) Operating Earnings of $2.74 per share for the first quarter of 2026 • Affirming full year 2026 Adjusted Operating Earnings guidance of $11.00 - $12.00 per share
Filing page
SEC filing
CMCT
CMCT Q1 net loss $34.7M; sells lending business for $44.9M, redeems $242.8M preferred stock
Creative Media & Community Trust Corp
May 8, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
was 91.4% as of March 31, 2026, representing a 1,120 basis point improvement from the first quarter of 2025. Financial Results • Net loss attributable to common stockholders of $(34.7) million, or $(70.52) per diluted share. • Funds from operations attributable to common stockholders (“FFO”) (3)1 was $(28.8) million, or $(58.47) per diluted share. • Core FFO
Filing page
SEC filing
CNTY
Century Casinos posts record Q1 net operating revenue of $137.2M; EBITDAR up 24%
CENTURY CASINOS INC /CO/
May 8, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
Net operating revenue was $137.2 million, an increase of 5%. · Earnings from operations was $11.8 million, an increase of 65%. · Net loss attributable to Century Casinos, Inc. shareholders was ($16.5) million, a change of 20%, and basic net loss per share was ($0.58).
Filing page
SEC filing
GLP
Global Partners Q1 net income surges to $70.1M ($1.85/unit) from $18.7M
GLOBAL PARTNERS LP
May 8, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 7.01, 9.01
similar materiality
This filing
Today, MoonLake also reported its financial results for the first quarter of 2026.
Comparable filing
Net income in the first quarter of 2026 was $70.1 million, or $1.85 per diluted common limited partner unit
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.